Prescription drug · ANDA
Plerixafor NDC 43598-308
Plerixafor 24 mg/1.2mL · Solution · Subcutaneous · Dr. Reddy's Laboratories Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 43598-308-23 | 43598030823 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-308-23) / 1.2 mL in 1 VIAL, SINGLE-DOSEMarketed from Nov 6, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Plerixafor
- Generic name (nonproprietary)
- plerixafor
- Active ingredients
- Plerixafor — 24 mg/1.2mL
- Dosage form
- Solution
- Route
- Subcutaneous
- Labeler
- Dr. Reddy's Laboratories Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205182
- Marketing start
- Listing expires
- Other FDA classes
- Increased Hematopoietic Stem Cell Mobilization (Physiologic effect)
- Identifiers
- Product ID 43598-308_1df6ec0d-0508-29af-33c2-3a9d19a040dfSPL ID 1df6ec0d-0508-29af-33c2-3a9d19a040dfSPL set ID 58c9fa02-3701-d411-f946-790a62ddc064RxCUI 828700UNII S915P5499NUPC 0343598308234
- Pharmacologic class
- Hematopoietic Stem Cell Mobilizer
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N443598030823followed by a unit qualifier and the quantityPackage 43598-0308-23. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Plerixafor injection is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM). Plerixafor injection, a hematopoietic stem cell mobilizer, is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma or multiple myeloma. ( 1 )
Excerpt only. Read the full label for complete information.